Induction of Plasmodium falciparum strain 2300 dormant forms by artemisinin

Main Article Content

Lilik Maslachah
Yoes Prijatna Dachlan
Chairul A. Nidom
Loeki Enggar Fitri


BACKGROUND The presence of Plasmodium falciparum resistance and decreased efficacy of artemisinin and its derivatives has resulted in the issue of malaria becoming increasingly complex, because there have been no new drugs as artemisinin replacements. The aims of this research were to evaluate in vitro changes in ultrastructural morphology of P. falciparum 2300 strain after exposure to artemisinin. METHODS The research used an experimental design with post test only control group. Cultures of P. falciparum 2300 strain in one control and one mutant group were treated by exposure to artemisinin at IC50 10-7 M for 48 hours. Ultrastructural phenotypic examination of ring, trophozoite and schizont morphology and developmental stage in the control and mutant group were done at 0, 12, 24, 36, 48 hours by making thin blood smears stained with 20% Giemsa for 20 minutes and examined using a microscope light at 1000x magnification. RESULTS Dormant forms occurred after 48 hours of incubation with IC50 10-7 M artemisinin in the control group. In the mutant group, dormant forms, trophozoites with blue cytoplasm and normal schizont developmental stages were seen. Ultrastructural phenotypic morphology at 0, 12, 24, 36, 48 hours showed that in the control group dormant formation already occurred with exposure to IC50 10-7 M, while in the mutant group dormant formation occurred only with exposure to IC50 2.5x10-5 M. CONCLUSION Exposure to artemisinin antimalarials in vitro can cause phenotypic morphological changes of dormancy in P. falciparum Papua 2300 strain.

Article Details

How to Cite
Maslachah, L., Dachlan, Y. P., Nidom, C. A., & Fitri, L. E. (2015). Induction of Plasmodium falciparum strain 2300 dormant forms by artemisinin. Universa Medicina, 34(1), 25–34.
Review Article


World Health Organization. World Health Organization global report on antimalarial drug efficacy and drug resistance 2000-2010. Geneva: World Health Organization; 2010.

Chima RI, Goodman CA, Mills A. The economic impact of malaria in Africa: a critical review of the evidence. Health Policy 2003;63:17-36.

Sachs J, Malaney P. The economic and social burden of malaria. Nature 2002;415:680-5.

Afonso A, Hunt P, Cheesman S, et al. Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase) tctp, mdr1 and cg10. Antimicrob Agents Chemother 2006;50:480-9.

Noedl H. Evidence of artemisinin resistant malaria in Western Cambodia. N Engl J Med 2008;359:2619-20.

Veiga MI, Ferreira PE, Schmidt BA, et al. Antimalarial exposure delays P. falciparum intraerytrocytic cycle and drives drug transporter genes expression. Plos One 2010;5:e12408.

Mugittu K, Genton B, Mshinda H, et al. Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania.

Malaria J 2006;5:126-128.

Schonfeld M, Miranda IB, Schunk M, et al. Molecular surveillance of drug resistance associated mutation of Plasmodium falciparum in Southwest Tanzania. Malaria J 2007;6:2. doi:10.1186/1475-2875-6-2.

Maslachah L. Efek paparan artemisinin berulang terhadap perkembangan Plasmodium falciparum resisten in vitro [disertasi]. Program Studi Ilmu Kedokteran Program Doktor. Surabaya: Fakultas Kedokteran Universitas Airlangga; 2013.

Witkowski B, Lelievre J, Barragan MJL, et al. Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism. Antimicrob Agents Chemother 2010;54:1872-7. doi: 10.1128/AAC.01636-09.

Beez D, Sanchez CP, Stein WD, et al. Genetic predisposition favors the acquisition of stable artemisinin resistance in malaria parasites. Antimicrob Agents Chemother 2010;55:50-5. doi: 10.1128/ACC.00916-10.

Sanz LM, Crespo B, De-cozar C, et al. P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode of action. Plos One 2012;7:e30949.

Teuscher F, Chen N, Kyle DE, et al. Phenotypic changes in artemisinin resistant Plasmodium falciparum line in vitro: evidence for decreased sensitivity to dormancy and growth inhibition. Antimicrob Agent Chemother 2012;56:428-31.

Cheng Q, Kyle DE, Gatton ML. Artemisinin resistance in Plasmodium falciparum: a process linked to dormancy. IJP 2012;2:249-55.

Babbit SE, Altenhofen L, Cobbold SA, et al. Plasmodium falciparum responds to amino acid starvation by entering into a hibernatory state. PNAS 2012;109:E3278-87.

Tucker MS, Mutka T, Gil M, et al. In vitro recrudescence of Plasmodium falciparum parasites suppressed todormant state by

atovaquone aloneand in combination with proguanil. J Trop Med Hygine 2005;99:62.

Phadke MS, Krynetskain NF, Mishra AK, et al. Glyceraldehyde 3-phosphate dehydrogenase depletion induces cell cycle arrest and resistance to antimetabolites in human carcinoma cell lines.

J Pharmacol Exp Ther 2009;331:77-86.

Tucker MS, Mutka T, Sparks K, et al. Phenotypic and genotypic analysis of in vitro selected artemisinin resistent progeny of Plasmodium falciparum. Antimicrob Agent Chemother 2012;56:302-14.

LaCrue AN, Scheel M, Kennedy K, et al. Effects of artesunate on parasite recrudescence and dormancy in the rodent malaria model Plasmodium vinckei. Plos One 2011;6:e26689.

Rosenthal PJ. Antimalaria chemotherapy mechanism of action resistance and new direction in drug discovery. J Antimicrob Chemother 2003;51:1053. doi: 10.1093/jac/dkg183

Cowman AF, Berry D, Baum J. The cellular and molecular basis for malaria parasite invasion of human red blood cell. JCB 2012;196:962-71.

Bonilla AJ, Bonilla DT, Yowell AC, et al. Critical roles for digestive vacuole plasmepsins of Plasmodium falciparum in vacuolar function. Molecular Microbiol 2007;65:64-75.

Klonis N, Ortiz MP, Bottova I, et al. Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion. PNAS 2011;108:11405-10.

Vieira A. Endocytic transport and some of its implications for physiology, metabolism and disease. J Physiobiochem Metab 2012;1:2.